Patrick Brancaccio John's Insider Trades & SAST Disclosures
Patrick Brancaccio John's most recent trade in Hepion Pharmaceuticals Inc was a trade of 85,000 Stock Options done . Disclosure was reported to the exchange on Feb. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick Brancaccio John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hepion Pharmaceuticals Inc | Patrick Brancaccio John | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 85,000 | 99,563 | - | - | Stock Options | |
| OKYO Pharma Limited - Ordi... | John Patrick Brancaccio | Independent Director | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 15 Mar 2023 | 554,561 | 554,561 (0%) | 0% | 1.5 | 831,842 | Ords |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 44,734 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 28,858 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 26,800 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 22,000 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 755 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 530 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 223 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 223 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Former Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 195 | 125,317 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 125,317 | - | - | Stock Options | |
| Hepion Pharmaceuticals Inc | John Patrick Brancaccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 200,000 | 291,332 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Director | Purchase of securities on an exchange or from another person at price $ 10.95 per share. | 22 Mar 2021 | 3,000 | 12,260 (0%) | 0% | 11.0 | 32,850 | Common Stock |
| Hepion Pharmaceuticals Inc | John Patrick Brancaccio | Director | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 02 Dec 2020 | 7,000 | 7,008 (0%) | 0% | 1.5 | 10,710 | Common Stock |
| Hepion Pharmaceuticals Inc | John Patrick Brancaccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 30,000 | 91,332 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 28,858 | 76,517 | - | - | Stock Options | |
| Cardiff Oncology Inc | John Patrick Brancaccio | Director | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 14 May 2020 | 6,993 | 9,260 (0%) | 0% | 1.4 | 10,000 | Common Stock |
| Hepion Pharmaceuticals Inc | John Patrick Brancaccio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 60,000 | 61,275 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges